01 Shift Towards Multimodal Brain Monitoring SystemsThe cerebral oximetry monitoring market analysis indicates a growing preference for systems that combine cerebral oxygenation measurement with brain function monitoring. Hospitals are adopting integrated platforms to assess oxygen saturation and neurological activity during complex surgical procedures. This supports more comprehensive patient assessment. For example, Masimo's Root platform combines O3 regional oximetry with SedLine brain function monitoring for simultaneous cerebral oxygenation and EEG assessment.
02 Expansion of Cerebral Oximetry Applications in Neonatal CareCerebral oximetry monitoring is gaining importance in neonatal intensive care, where premature infants require continuous assessment of cerebral oxygen saturation. Manufacturers are developing specialized sensors for smaller patients and expanding monitoring parameters for pediatric applications. This trend supports wider clinical use beyond adult cardiac surgery.
01 Supply chain disruptions are expected to have a moderate impact on the cerebral oximetry monitoring market share due to shortages of optical sensors, semiconductor components, and medical-grade materials. The market is expected to experience a K-shaped recovery, as established manufacturers with diversified suppliers can maintain production stability. Smaller manufacturers remain more exposed to component shortages and higher procurement costs. The market is projected to grow at a CAGR of 6.95%. A potential reduction of 1.5 percentage points could lower short-term growth to 5.45%. Improved component availability and stable manufacturing operations are expected to support recovery toward the projected 6.95% growth rate.
01 The cerebral oximetry monitoring market forecasts continued investment in non-invasive brain monitoring technologies, supporting optical sensor development, clinical validation, and regulatory approvals.
02 Key Investment and Funding Activities in Cerebral Oximetry Monitoring Market, 2025–2026CompanyValue (USD)DetailsBioscan ResearchUSD 1 MillionIn July 2026, Bioscan Research raised seed funding to expand its NIRS-based brain injury detection technology and support regulatory approvals.CoMindUSD 60 MillionIn October 2025, CoMind secured funding to advance its optical brain monitoring technology, clinical trials, and regulatory approval activities.
01 Adoption of Cerebral Oxygenation Monitoring and Demand for Integrated Cerebral Oximetry & Hemodynamic Monitoring Devices Drives MarketCardiopulmonary bypass procedures strengthen demand for cerebral oximetry monitoring systems. These devices help clinicians detect reduced cerebral oxygen saturation during surgery. The EACTS/EACTAIC/EBCP guidelines provide a Class IIa recommendation with Level B evidence for considering NIRS-guided algorithms to detect cerebral hypoperfusion. This clinical recognition supports wider adoption of cerebral oximetry systems in cardiac operating rooms and specialized surgical centers.Hospitals are adopting systems that display cerebral oxygen saturation alongside blood pressure and blood flow parameters. For instance, Edwards Lifesciences' ForeSight tissue oximetry system integrates with the HemoSphere advanced monitoring platform to provide a combined assessment of tissue oxygenation and hemodynamics. This integration supports efficient clinical assessment and encourages investment in advanced monitoring equipment.
01 High Cost of Disposable Cerebral Oximetry Sensors and Measurement Variability Limit Market ExpansionThe recurring cost of disposable cerebral oximetry sensors remains a major restraint on market expansion. Cerebral oximetry systems require patient-specific adhesive sensors that are generally replaced after each procedure. This increases operating expenses for hospitals with high surgical volumes.Cerebral oximetry measurements are vulnerable to interference from scalp blood flow and differences in skin pigmentation. These factors can affect the accuracy of regional cerebral oxygen saturation readings. The U.S. FDA has identified skin pigmentation as a potential source of measurement variation in biomedical optical devices, including cerebral oximeters.
01 Development of Advanced Optical Sensors with Signal Correction Technology and Integration of Cerebral Oximetry with Automated Perfusion Management Creates Growth OpportunitiesDevelopment of multi-distance near-infrared spectroscopy (NIRS) technology creates opportunities for manufacturers to improve the accuracy of cerebral oximetry devices. Conventional systems can experience signal interference from scalp tissues, affecting brain oxygenation measurements. Advanced short-separation sensors can reduce this interference and improve measurement reliability. Integration of cerebral oximetry with automated perfusion monitoring presents opportunities for manufacturers to develop advanced surgical monitoring platforms. These systems could combine cerebral oxygen saturation readings with blood pressure and cardiopulmonary bypass parameters. Automated algorithms could identify concerning oxygenation changes and support earlier clinical intervention.